Higher levels of HIV DNA in memory and naive CD4+ T cell subsets of viremic compared to non-viremic patients after 18 and 24 months of HAART

Antiviral Research

Volumn 50, Issue 3, 2001, Pages 197-206

  Baldanti, Fausto ^a   Paolucci, Stefania ^a   Gulminetti, Roberto ^a   Maserati, Renato ^b   Migliorinol, Guglielmo ^c   Panl, Angelo ^d   Maggiolol, Franco ^e   Comolli, Giuditta ^a   Chiesa, Antonella ^a   Gerna, Giuseppe ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c OSPEDALE DI CIRCOLO   (Italy)

^d Divisione di Malattie Infettive   (Italy)

^e OSPEDALI RIUNITI   (Italy)

Author keywords

HAART; HIV DNA; Memory CD4+ T cells; Naive CD4+ T cells

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; LAMIVUDINE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; VIRUS DNA; VIRUS RNA; ZIDOVUDINE;

ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MEMORY CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; T LYMPHOCYTE; VIREMIA; VIRUS INFECTION; VIRUS LOAD;

ANTI-HIV AGENTS; ANTIGENS, CD45; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4-POSITIVE T-LYMPHOCYTES; CROSS-SECTIONAL STUDIES; DNA, VIRAL; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOLOGIC MEMORY; L-SELECTIN; POLYMERASE CHAIN REACTION; RNA, VIRAL; T-LYMPHOCYTE SUBSETS; VIRAL LOAD; VIREMIA;

EID: 0035021013     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(01)00142-5     Document Type: Article

References (17)

1. Dynamics of molecular parameters of human immunodeficiency virus type 1 activity in vivo
2. Immune reconstitution in the first year of potent antiretroviral therapy and its relationship to virologic response
3. + T-cell repertoire that are not immediately restored by antiviral or immune-based therapies
4. Dissociation of immunologic and virologic responses to highly active antiretroviral therapy
5. Changes in CD4+ and CD8+ T cell subset in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience
6. Quantification of integrated and total HIV-1 DNA after long-term active antiretroviral therapy in HIV-1-infected patient
7. CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART)
8. Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T cell turnover in HIV-infected patients
9. Improvement in CD4+ T cell counts despite persistently detectable HIV load
10. Long-lasting recovery in CD4 T-cell functions and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease
11. Viral load and burden modification following early antiretroviral treatment of primary HIV-1 infection
12. Cell-associated infectious HIV-1 viral load as a predictor of clinical progression and survival among HIV-1 infected injection drug users and homosexual men
13. Long-term evaluation of T-cell subsets and T-cell function after HAART in advanced stage HIV-1 disease
14. + T cells are infected in human immunodeficiency virus type 1-infected individuals
15. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferation
16. CD4+ memory T cells are the predominant population of HIV-1-infected lymphocytes in neonates and children
17. + memory cell subset of primary CD4 lymphocytes in vitro